Immunosuppressive drugs for kidney transplantation

被引：1106

作者：

Halloran, PF ^{[1
]}

机构：

[1] Univ Alberta, Div Nephrol & Transplantat Immunol, Edmonton, AB, Canada

来源：

NEW ENGLAND JOURNAL OF MEDICINE | 2004年 / 351卷 / 26期

关键词：

D O I：

10.1056/NEJMra033540

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：2715 / 2729

页数：15

共 126 条

[1] Heterologous immunity provides a potent barrier to transplantation tolerance [J].

Adams, AB ;

Williams, MA ;

Jones, TR ;

Shirasugi, N ;

Durham, MM ;

Kaech, SM ;

Wherry, EJ ;

Onami, T ;

Lanier, JG ;

Kokko, KE ;

Pearson, TC ;

Ahmed, R ;

Larsen, CP .

JOURNAL OF CLINICAL INVESTIGATION, 2003, 111 (12) :1887-1895

[2] Randomized trial of tacrolimus plus mycophenolate mofetil or azathioprine versus cyclosporine oral solution (modified) plus mycophenolate mofetil after cadaveric kidney transplantation: Results at 2 years [J].

Ahsan, N ;

Johnson, C ;

Gonwa, T ;

Halloran, P ;

Stegall, M ;

Hardy, M ;

Metzger, R ;

Shield, C ;

Rocher, L ;

Scandling, J ;

Sorensen, J ;

Mulloy, L ;

Light, J ;

Corwin, C ;

Danovitch, G ;

Wachs, M ;

VanVeldhuisen, P ;

Salm, K ;

Tolzman, D ;

Fitzsimmons, WE .

TRANSPLANTATION, 2001, 72 (02) :245-250

[3]

ALLISON AC, 1975, LANCET, V2, P1179

[4] In search of the elusive holy grail: The mechanisms and prospects for achieving clinical transplantation tolerance [J].

Auchincloss, H .

AMERICAN JOURNAL OF TRANSPLANTATION, 2001, 1 (01) :6-12

[5]

Bartolomeo G, 1896, Riv. d'Ingienne e Sanita Publica, V7, P825

[6] CALCINEURIN ACTIVITY IS ONLY PARTIALLY INHIBITED IN LEUKOCYTES OF CYCLOSPORINE-TREATED PATIENTS [J].

BATIUK, TD ;

PAZDERKA, F ;

HALLORAN, PF .

TRANSPLANTATION, 1995, 59 (10) :1400-1404

[7] Rituximab as treatment for refractory kidney transplant rejection [J].

Becker, YT ;

Becker, BN ;

Pirsch, JD ;

Sollinger, HW .

AMERICAN JOURNAL OF TRANSPLANTATION, 2004, 4 (06) :996-1001

[8] Concomitant inhibition of janus kinase 3 and calcineurin-dependent signaling pathways synergistically prolongs the survival of rat heart allografts [J].

Behbod, F ;

Erwin-Cohen, RA ;

Wang, ME ;

Trawick, BW ;

Qu, X ;

Verani, R ;

Kahan, BD ;

Stepkowski, SM ;

Kirken, RA .

JOURNAL OF IMMUNOLOGY, 2001, 166 (06) :3724-3732

[9]

Biedermann BC, 1998, J IMMUNOL, V161, P4679

[10] Effects of sirolimus on lipids in renal allograft recipients: An analysis using the Framingham risk model [J].

Blum, CB .

AMERICAN JOURNAL OF TRANSPLANTATION, 2002, 2 (06) :551-559

← 1 2 3 4 5 6 7 8 9 10 →